Conmed Stock News

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Surgical stapling devices also referred to surgical staplers, are medical devices that are used for wound closure or closure of incision after a surgery is performed. The Global Surgical Stapling Devices Market Report presents a comprehensive overview of the market

Equities research analysts forecast that CONMED Co. (NYSE:CNMD) will post $1.06 earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Four analysts have provided estimates for CONMEDs earnings. The lowest EPS estimate is $1.05 and the highest is $1.07. CONMED posted earnings of $0.84 per share in the same quarter last []

Market Players for Global Laparoscopy Devices Market Stryker Corporation, Karl Storz GmbH & Co KG, Boston Scientific Corporation, Medtronic PLC, Intuitive Surgical, (Japan), Karl Storz GmbH, Olympus Corporation, Microline Surgical, Medtronic PLC. Johnson & Johnson, Olympus Corporation, Conmed Corporation Market Players for Global Laparoscopy Devices Market Stryker Corporation, Karl Storz GmbH & Co KG, Boston Scientific Corporation, Medtronic PLC, Intuitive Surgical, (Japan), Karl Storz GmbH, Olympus Corporation, Microline Surgical, Medtronic PLC. Johnson & Johnson, Olympus Corporation, Conmed Corporation

Wall Street brokerages expect that CONMED Co. (NYSE:CNMD) will report sales of $278.81 million for the current quarter, Zacks reports. Four analysts have made estimates for CONMEDs earnings, with the highest sales estimate coming in at $279.80 million and the lowest estimate coming in at $278.40 million. CONMED reported sales of $252.83 million in the []

HSIC vs. CNMD: Which Stock Is the Better Value Option?

CONMED's (CNMD) third-quarter earnings reflect strong segmental performance.

CONMED's (CNMD) CEO Curt Hartman on Q3 2021 Results - Earnings Call Transcript

Conmed (CNMD) delivered earnings and revenue surprises of 3.90% and -2.51%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Conmed (NYSE:CNMD) reported its Q3 earnings results on Wednesday, October 27, 2021 at 04:05 PM. Here's what investors need to know about the announcement.

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the third quarter 2021 after the market close on October 27, 2021. The Company's

Investors continue to be optimistic about CONMED (CNMD) owing to its broad product spectrum.

Conmed (CNMD) reported earnings 30 days ago. What's next for the stock?

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on October 5, 2021 to all s